000			01848 a2200481 4500
005			20250517003511.0
264		0	_c20150924
008			201509s 0 0 eng d
022			_a1463-1326
024	7		_a10.1111/dom.12417 _2doi
040			_aNLM _beng _cNLM
100	1		_aAbdul-Ghani, M A
245	0	0	_aInitial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial. _h[electronic resource]
260			_bDiabetes, obesity & metabolism _cMar 2015
300			_a268-75 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aDiabetes Mellitus, Type 2 _xcomplications
650	0	4	_aDrug Therapy, Combination _xmethods
650	0	4	_aExenatide
650	0	4	_aFemale
650	0	4	_aGlycated Hemoglobin _xdrug effects
650	0	4	_aHumans
650	0	4	_aHypoglycemia _xchemically induced
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin Resistance
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPeptides _xtherapeutic use
650	0	4	_aPioglitazone
650	0	4	_aThiazolidinediones _xtherapeutic use
650	0	4	_aVenoms _xtherapeutic use
650	0	4	_aWeight Gain _xdrug effects
650	0	4	_aWeight Loss _xdrug effects
700	1		_aPuckett, C
700	1		_aTriplitt, C
700	1		_aMaggs, D
700	1		_aAdams, J
700	1		_aCersosimo, E
700	1		_aDeFronzo, R A
773	0		_tDiabetes, obesity & metabolism _gvol. 17 _gno. 3 _gp. 268-75
856	4	0	_uhttps://doi.org/10.1111/dom.12417 _zAvailable from publisher's website
999			_c24380872 _d24380872